Buprenorphine Hydrochloride
Product Images NDC 21695-515

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 21695-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Buprenorphine Hydrochloride (6795ade9 E06e 4daa Bb45 821901a055f5 01)

Structural Formula Buprenorphine Hydrochloride (6795ade9 E06e 4daa Bb45 821901a055f5 01)
Chemical structure of Buprenorphine Hydrochloride showing its molecular framework with hydroxyl, methoxy, and nitrogen-containing groups.*
FDA Label Image

Buprenorphine HCl 0.3mg (6795ade9 E06e 4daa Bb45 821901a055f5 02)

Buprenorphine HCl 0.3mg (6795ade9 E06e 4daa Bb45 821901a055f5 02)
Label for Buprenorphine HCl 0.3 mg injection in 1 ml/10 vials. Distributed by Physician Partner, the label shows the product ID RB051510, lot number, expiration date, and manufacturer as Hospira Inc. It includes dosing equivalence and storage instructions at controlled room temperature, along with a caution to keep medication away from children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.